FDA
-
-
-
-
-
-
-
Midday movers: Estee Lauder, Eli Lilly and more
-
-
-
-
-
-
-
Sarepta (SRPT) and Catalent (CTLT) Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics and Catalent Announce Completion of Technology Transfer for NurOwn® Manufacturing
-
-
-
-
-
-
-
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003)
-
-
-
-
-
-
-
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT), Catalent (CTLT) Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
-
-
-
-
-
-
-
Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

